We spoke with Susan E. Schindler, MD, PhD, lead author of a study about the effect of race on the prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light.
For adults hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, encephalopathy at admission is the most common serious neurologic manifestation, all of which are associated with worse outcomes.
Researchers suspect patients with neurofibromatosis type 1 experience a dysregulation of melanocytogenesis, inducing abnormal polarization on both sides of RPE.
The US Food and Drug Administration granted marketing approval for the Lumipulse G β-Amyloid Ratio (1-42/1-40) test, the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer disease.
The patient also reported persistent muscle soreness after exertion. Can you diagnose his condition?
Richard K. Bogan, MD, discusses the importance of lowering sodium intake and improving heart health for patients with narcolepsy.
Antioxidants such as serum level of lutein+zeaxanthin and β-cryptoxanthin are associated with a reduced risk for all-cause dementia.
Multidomain interventions are equally effective for improving cognition in women and men.
Researchers sought to identify the neuropathologic changes of COVID-19 in the olfactory region of patients who died with COVID-19 infection.
Approximately 3% of patients with pneumonia associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection subsequently develop dementia.
